Ofer Mandelboim,Angel Porgador,Yaakov Naparstek,Chamutal Gur
申请号：
US13257349
公开号：
US20120076753A1
申请日:
2010.03.18
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention relates to use of the natural cytotoxicity receptor NKp46 for preventing and treating diabetes, including type I diabetes (TID) and type 2 diabetes. In particular, the invention provides compositions comprising a fragment of the extracellular region of NKp46 for preventing the onset and progression of diabetes.
